SP33 Type D Personality as an Independent Predictor of the Metabolic Syndrome

Abstract Background Type D personality is a combination of high negative affectivity (NA) and high social inhibition (SI). This personality trait is suspected to impair cardiovascular patients’ recovery. The 2016 European Guidelines on cardiovascular disease prevention in clinical practice recommend screening of psychosocial risk factors as Type D personality. The aim of this study was to assess the relationship between Type D personality and Metabolic syndrome (MetS) in working-age female population. Methods Six hundred thirty-four female employees with mean age of 48 ± 10 years were evaluated. Type D personality and its components (NA) and (SI) were screened with DS14 questionnaire. The definition of MetS was based on measurements done by trained medical staff. We investigated the relationship between Mets and Type D personality, NA and SI using the logistic regression models adjusting for age, education years, leisure-time physical activity, smoking, alcohol use and depressive symptoms. Results The prevalence of Type D personality was 10.6% (n = 67) [95% CI: 8.3 to 13.2] and MetS 34.7% (n = 220). Type D personality or its subcomponents were not associated with MetS. Women with Type D personality had significantly worse quality of sleep and lower LTPA. They were also more often unsatisfied with their economic situation, they had more often depressive symptoms and psychiatric disorders than non-D type persons. There were no differences in risk factors for cardiovascular diseases. Conclusion Screening for Type D personality among working- age, reasonably healthy female population seems not to be practical method for finding persons with risk for cardiovascular disease.

Download Full-text

Baseline forced expiratory volume in the first second as an independent predictor of development of the metabolic syndrome

Metabolism ◽

10.1016/j.metabol.2009.10.001 ◽

2010 ◽

Vol 59 (6) ◽

pp. 848-853 ◽

Cited By ~ 11

Author(s):

Fone-Ching Hsiao ◽

Chung-Ze Wu ◽

Sheng-Chiang Su ◽

Ming-Tsung Sun ◽

Chang-Hsun Hsieh ◽

...

Keyword(s):

Metabolic Syndrome ◽

Independent Predictor ◽

Forced Expiratory Volume ◽

The Metabolic Syndrome

Download Full-text

Type D Personality and Metabolic Syndrome in Patients With Depression

10.26226/morressier.58c95392d462b8028d8910b7 ◽

2017 ◽

Author(s):

Marko Martinac

Keyword(s):

Metabolic Syndrome ◽

Type D Personality ◽

Type D

Download Full-text

C-Reactive Protein is a Strong Independent Predictor of Death in Type 2 Diabetes: Association with Multiple Facets of the Metabolic Syndrome

Experimental and Clinical Endocrinology & Diabetes ◽

10.1055/s-2006-924012 ◽

2006 ◽

Vol 114 (03) ◽

pp. 127-134 ◽

Cited By ~ 25

Author(s):

B. Linnemann ◽

W. Voigt ◽

W. Nobel ◽

H. Janka

Keyword(s):

Type 2 Diabetes ◽

Metabolic Syndrome ◽

Independent Predictor ◽

C Reactive Protein ◽

Reactive Protein ◽

The Metabolic Syndrome ◽

Strong Independent Predictor

Download Full-text

Metabolic syndrome and the risk of adverse cardiovascular events after an acute coronary syndrome

European Journal of Preventive Cardiology ◽

10.1177/2047487318763897 ◽

2018 ◽

Vol 25 (8) ◽

pp. 830-838 ◽

Cited By ~ 5

Author(s):

Ilaria Cavallari ◽

Christopher P Cannon ◽

Eugene Braunwald ◽

Erica L Goodrich ◽

KyungAh Im ◽

...

Keyword(s):

Myocardial Infarction ◽

Metabolic Syndrome ◽

Acute Coronary Syndrome ◽

Prognostic Value ◽

Independent Predictor ◽

Adverse Outcomes ◽

Coronary Syndrome ◽

The Metabolic Syndrome ◽

Incremental Value ◽

Coronary Events

Background The incremental prognostic value of assessing the metabolic syndrome has been disputed. Little is known regarding its prognostic value in patients after an acute coronary syndrome. Design and methods The presence of metabolic syndrome (2005 International Diabetes Federation) was assessed at baseline in SOLID-TIMI 52, a trial of patients within 30 days of acute coronary syndrome (median follow-up 2.5 years). The primary endpoint was major coronary events (coronary heart disease death, myocardial infarction or urgent coronary revascularization). Results At baseline, 61.6% ( n = 7537) of patients met the definition of metabolic syndrome, 34.7% (n = 4247) had diabetes and 29.3% had both ( n = 3584). The presence of metabolic syndrome was associated with increased risk of major coronary events (adjusted hazard ratio (adjHR) 1.29, p < 0.0001) and recurrent myocardial infarction (adjHR 1.30, p < 0.0001). Of the individual components of the definition, only diabetes (adjHR 1.48, p < 0.0001) or impaired fasting glucose (adjHR 1.21, p = 0.002) and hypertension (adjHR 1.46, p < 0.0001) were associated with the risk of major coronary events. In patients without diabetes, metabolic syndrome was numerically but not significantly associated with the risk of major coronary events (adjHR 1.13, p = 0.06). Conversely, diabetes was a strong independent predictor of major coronary events in the absence of metabolic syndrome (adjHR 1.57, p < 0.0001). The presence of both diabetes and metabolic syndrome identified patients at highest risk of adverse outcomes but the incremental value of metabolic syndrome was not significant relative to diabetes alone (adjHR 1.07, p = 0.54). Conclusions After acute coronary syndrome, diabetes is a strong and independent predictor of adverse outcomes. Assessment of the metabolic syndrome provides only marginal incremental value once the presence or absence of diabetes is established.

Download Full-text